{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:53:04Z","timestamp":1769608384028,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s13760-018-0906-z","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:45:49Z","timestamp":1520556349000},"page":"179-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Single-centre experience on transthyretin familial amyloid polyneuropathy: case series and literature review"],"prefix":"10.1007","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6324-2857","authenticated-orcid":false,"given":"Broes","family":"Martens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"De Pauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan L.","family":"De Bleecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"906_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(11)70246-0","author":"V Plante-Bordeneuve","year":"2011","unstructured":"Plante-Bordeneuve V, Said G (2011) Familial amyloid polyneuropathy. Lancet Neurol. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(11)70246-0","journal-title":"Lancet Neurol"},{"key":"906_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22619","author":"DM Rowczenio","year":"2014","unstructured":"Rowczenio DM, Noor I, Gillmore JD, Lachmann HJ, Whelan C, Hawkins PN et al (2014) Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum Mutat. \n                    https:\/\/doi.org\/10.1002\/humu.22619","journal-title":"Hum Mutat"},{"key":"906_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/1756285612470192","author":"D Adams","year":"2013","unstructured":"Adams D (2013) Recent advances in the treatment of familial amyloid polyneuropathy. Ther Adv Neurol Disord. \n                    https:\/\/doi.org\/10.1177\/1756285612470192","journal-title":"Ther Adv Neurol Disord"},{"key":"906_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.111.078915","author":"FL Ruberg","year":"2012","unstructured":"Ruberg FL, Berk JL (2012) Transthyretin (TTR) cardiac amyloidosis. Circulation. \n                    https:\/\/doi.org\/10.1161\/circulationaha.111.078915","journal-title":"Circulation"},{"key":"906_CR5","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1212\/WNL.58.7.1001","volume":"58","author":"S Ikeda","year":"2002","unstructured":"Ikeda S, Nakazato M, Ando Y, Sobue G (2002) Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 58:1001\u20131007","journal-title":"Neurology"},{"key":"906_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/wco.0000000000000289","author":"D Adams","year":"2016","unstructured":"Adams D, Suhr OB, Hund E, Obici L, Tournev I, Campistol JM et al (2016) First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Curr Opin Neurol. \n                    https:\/\/doi.org\/10.1097\/wco.0000000000000289","journal-title":"Curr Opin Neurol"},{"key":"906_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1210\/endo\/130.2.1733735","volume":"130","author":"JP Chanoine","year":"1992","unstructured":"Chanoine JP, Alex S, Fang SL, Stone S, Leonard JL, Korhle J et al (1992) Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid, and the brain. Endocrinology 130:933\u2013938. \n                    https:\/\/doi.org\/10.1210\/endo\/130.2.1733735","journal-title":"Endocrinology"},{"key":"906_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25210","author":"HH-J Schmidt","year":"2016","unstructured":"Schmidt HH-J, Barroso F, Gonzalez-Duarte A, Conceicao I, Obici L, Keohane D et al (2016) Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy. Muscle Nerve. \n                    https:\/\/doi.org\/10.1002\/mus.25210","journal-title":"Muscle Nerve"},{"key":"906_CR9","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000004178","author":"J Kollmer","year":"2017","unstructured":"Kollmer J, Sahm F, Hegenbart U, Purrucker JC, Kimmich C, Schonland SO et al (2017) Sural nerve injury in familial amyloid polyneuropathy: MR neurography vs clinicopathologic tools. Neurology. \n                    https:\/\/doi.org\/10.1212\/wnl.0000000000004178","journal-title":"Neurology"},{"key":"906_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1121005109","author":"CE Bulawa","year":"2012","unstructured":"Bulawa CE, Connelly S, DeVit M, Wang L, Weigel C, Fleming JA et al (2012) Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci. \n                    https:\/\/doi.org\/10.1073\/pnas.1121005109","journal-title":"Proc Natl Acad Sci"},{"key":"906_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.283815","author":"JL Berk","year":"2013","unstructured":"Berk JL, Suhr OB, Obici L, Sekijima Y, Zeldenrust SR, Yamashita T et al (2013) Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. JAMA. \n                    https:\/\/doi.org\/10.1001\/jama.2013.283815","journal-title":"JAMA"},{"key":"906_CR12","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000003018","author":"T Cavallaro","year":"2016","unstructured":"Cavallaro T, Klunk W (2016) PiB-PET detects transthyretin-related cerebral amyloid angiopathy. Neurology. \n                    https:\/\/doi.org\/10.1212\/wnl.0000000000003018","journal-title":"Neurology"},{"key":"906_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003001","author":"Y Sekijima","year":"2016","unstructured":"Sekijima Y, Yazaki M, Oguchi K, Ezawa N, Yoshinaga T, Yamada M (2016) Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis. Neurology. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003001","journal-title":"Neurology"},{"key":"906_CR14","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0b013e3181ea15d4","author":"JJ Liepnieks","year":"2010","unstructured":"Liepnieks JJ, Zhang LQ, Benson MD (2010) Progression of transthyretin amyloid neuropathy after liver transplantation. Neurology. \n                    https:\/\/doi.org\/10.1212\/wnl.0b013e3181ea15d4","journal-title":"Neurology"},{"key":"906_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12193","author":"C Franz","year":"2013","unstructured":"Franz C, Hoffmann K, Hinz U, Singer R, Hund E, Gotthardt DN et al (2013) Modified body mass index and time interval between diagnosis and operation affect survival after liver transplantation for hereditary amyloidosis: a single-center analysis. Clin Transplant. \n                    https:\/\/doi.org\/10.1111\/ctr.12193","journal-title":"Clin Transplant"},{"key":"906_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000001975","author":"N Wange","year":"2017","unstructured":"Wange N, Anan I, Ericzon B-G, Pennlert J, Pilebro B, Suhr OB et al (2017) Atrial fibrillation and central nervous complications in liver transplanted hereditary transthyretin amyloidosis patients. Transplantation. \n                    https:\/\/doi.org\/10.1097\/tp.0000000000001975","journal-title":"Transplantation"},{"key":"906_CR17","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2009.08016","author":"M Eriksson","year":"2009","unstructured":"Eriksson M, Buttner J, Todorov T, Yumlu S, Schonland S, Hegenbart U et al (2009) Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid. Am J Surg Pathol. \n                    https:\/\/doi.org\/10.2353\/jmoldx.2009.08016","journal-title":"Am J Surg Pathol"},{"key":"906_CR18","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1208760","author":"T Coelho","year":"2013","unstructured":"Coelho T, Adams D, Silva A, Lozeron P, Hawkins PN, Mant T et al (2013) Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med. \n                    https:\/\/doi.org\/10.1056\/nejmoa1208760","journal-title":"N Engl J Med"},{"key":"906_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/wco.0000000000000290","author":"L Obici","year":"2016","unstructured":"Obici L, Kuks JB, Buades J, Adams D, Suhr OB, Coelho T et al (2016) Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis. Curr Opin Neurol. \n                    https:\/\/doi.org\/10.1097\/wco.0000000000000290","journal-title":"Curr Opin Neurol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-018-0906-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-018-0906-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-018-0906-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T19:05:13Z","timestamp":1552071913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-018-0906-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1007\/s13760-018-0906-z","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]},"assertion":[{"value":"11 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}